Zura Bio Limited (ZURA)
NASDAQ: ZURA · IEX Real-Time Price · USD
3.620
+0.310 (9.37%)
At close: Apr 25, 2024, 4:00 PM
3.780
+0.160 (4.42%)
Pre-market: Apr 26, 2024, 6:32 AM EDT

Zura Bio Statistics

Total Valuation

Zura Bio has a market cap or net worth of $225.62 million. The enterprise value is $125.81 million.

Market Cap 225.62M
Enterprise Value 125.81M

Important Dates

The next estimated earnings date is Sunday, May 12, 2024, before market open.

Earnings Date May 12, 2024
Ex-Dividend Date n/a

Share Statistics

Zura Bio has 62.33 million shares outstanding. The number of shares has increased by 14,392.36% in one year.

Shares Outstanding 62.33M
Shares Change (YoY) +14,392.36%
Shares Change (QoQ) -29.47%
Owned by Insiders (%) 40.68%
Owned by Institutions (%) 32.75%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.80
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.97, with zero debt.

Current Ratio 4.97
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -126.30% and return on invested capital (ROIC) is -105.58%.

Return on Equity (ROE) -126.30%
Return on Assets (ROA) -76.30%
Return on Capital (ROIC) -105.58%
Revenue Per Employee n/a
Profits Per Employee -$4.95M
Employee Count 14
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -53.17% in the last 52 weeks. The beta is 0.54, so Zura Bio's price volatility has been lower than the market average.

Beta (1Y) 0.54
52-Week Price Change -53.17%
50-Day Moving Average 3.21
200-Day Moving Average 4.84
Relative Strength Index (RSI) 59.60
Average Volume (30 Days) 289,291

Short Selling Information

The latest short interest is 428,370, so 0.69% of the outstanding shares have been sold short.

Short Interest 428,370
Short Previous Month 628,327
Short % of Shares Out 0.69%
Short % of Float n/a
Short Ratio (days to cover) 0.79

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -62.64M
Pretax Income -60.36M
Net Income -69.24M
EBITDA -60.36M
EBIT -60.36M
Earnings Per Share (EPS) -$2.09
Full Income Statement

Balance Sheet

The company has $99.81 million in cash and no debt, giving a net cash position of $99.81 million or $1.60 per share.

Cash & Cash Equivalents 99.81M
Total Debt n/a
Net Cash 99.81M
Net Cash Per Share $1.60
Equity / Book Value 59.33M
Book Value Per Share 0.95
Working Capital 80.54M
Full Balance Sheet

Cash Flow

Operating Cash Flow -15.05M
Capital Expenditures n/a
Free Cash Flow -15.05M
FCF Per Share -$0.46
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Zura Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -14,392.36%
Shareholder Yield -14,392.36%
Earnings Yield -30.69%
FCF Yield -6.67%

Analyst Forecast

The average price target for Zura Bio is $16.50, which is 355.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target $16.50
Price Target Difference 355.80%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2